Skip to content
DraconiticResearch
Search Sources API
203,234 studies31 sourcesUpdated 54 min ago
Peer-reviewedCC BY-NC-NDTranslational andrology and urology

The PROSA and cons of prostate cancer screening.

  1. 1Department of Radiology, Massachusetts General Hospital, Mass General Brigham, Boston, MA, USA.
  2. 2Harvard Medical School, Boston, MA, USA.

Related

  1. Prostate-specific antigen (PSA) test for prostate cancer screening
    Juan Víctor Ariel Franco, Eu Chang Hwang, Jae Hung Jung +4
    Cochrane Database of Systematic ReviewsPeer-reviewedLicence not stated11 citedGeneral medicineOpenAlex
  2. 4Kscore as a Pre-MRI Reflex Test for Men with PSA 1.80–2.99 ng/ml in the Göteborg-2 Prostate Cancer Screening Trial
    Fredrik Möller, Andreas Josefsson, Marianne Månsson +6
    European Urology Open SciencePeer-reviewedCC BYFull textOncologyDOAJEurope PMCEurope PMCPMC
  3. The Pros & Cons of Measuring Plasma Ammonia in the Management of Patients With Cirrhosis: An ISHEN Debate
    Maria Pilar Ballester, Patricia Bloom, Christopher F. Rose
    Liver international : official journal of the International Association for the Study of the LiverPeer-reviewedCC BYFull textGeneral medicineEurope PMC
  4. Case Report: Prostatic infarction mimicking prostate cancer in a patient with markedly elevated prostate-specific antigen
    Huajian Ye, Yaokang Chen, Liming Yu
    Frontiers in medicinePeer-reviewedCC BYFull textGeneral medicineEurope PMC
  5. Cancer‐Related Fever in Metastatic Prostate Cancer: A Case Report
    Masoud Maboudi, Maryam Montazeri, Sara Ghandi +1
    Clinical case reportsPeer-reviewedCC BY-NC-NDFull textGeneral medicineEurope PMC
BibTeX
@article{cochran2026prosa,
  title = {{The PROSA and cons of prostate cancer screening.}},
  author = {Rory L Cochran and Mukesh G Harisinghani},
  journal = {Translational andrology and urology},
  year = {2026},
  month = oct,
  doi = {10.21037/tau-2026-0791},
  url = {https://europepmc.org/article/MED/42997103},
  note = {CC BY-NC-ND},
}
RIS
TY  - JOUR
TI  - The PROSA and cons of prostate cancer screening.
AU  - Rory L Cochran
AU  - Mukesh G Harisinghani
PY  - 2026
DA  - 2026/10/22
JO  - Translational andrology and urology
DO  - 10.21037/tau-2026-0791
UR  - https://europepmc.org/article/MED/42997103
SN  - 2223-4691
ER  -